停用增加跌倒风险药物对多重共病多重用药老年患者跌倒的影响
本研究基于OPERAM整群随机对照试验数据,纳入1546例≥70岁多重共病多重用药且基线使用增加跌倒风险药物(FRID)的老年患者。随访2个月内57%停用至少一种FRID,1年内24%发生跌倒;
要点
- 多重共病多重用药老年患者中跌倒高发,1年内24%发生跌倒。
- 整体停用FRID与跌倒或反复跌倒发生无显著关联。
- 既往跌倒者停用抗精神病药与跌倒发生降低相关。
核心结论
- 在多重共病使用FRID的老年患者中,跌倒高度流行,但停用FRID与跌倒风险整体无关联。
研究设计与样本
- 本研究为基于整群随机对照试验OPERAM的二次分析,该试验评估医院药物治疗优化。
- 纳入标准为年龄≥70岁、多重共病、多重用药、基线使用FRID、随访2个月时存活且提供跌倒数据的成人。
- FRID停用定义为入组后2个月内停用至少1种FRID,包括抗抑郁药、抗癫痫药、抗组胺药、抗精神病药、苯二氮䓬类和z类药物、利尿剂、阿片类和α受体阻滞剂。
- 采用多变量Cox回归分析并结合逆概率加权评估FRID停用与跌倒发生的关联。
- 共纳入1546例参与者,中位年龄79岁(IQR 74-84),女性占45%。
主要发现
- 随访2个月后,878例(57%)参与者停用了FRID。
- 随访1年内,378例(24%)参与者发生跌倒,137例(9%)发生2次及以上跌倒,199例(13%)发生严重跌倒。
- 整体而言,FRID停用与跌倒发生之间未发现关联。
关键数值与推荐
- FRID停用定义为入组后2个月内停用至少1种FRID。
- 跌倒结局包括1年内任何跌倒、反复跌倒(2次及以上)和严重跌倒。
临床怎么用
- 对多重共病多重用药老年患者应关注FRID使用及跌倒风险,但整体停用FRID未必降低跌倒。
- 对既往有跌倒史的患者,可考虑评估并停用抗精神病药以降低跌倒风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Falls are a major concern in the older population. An important cause of falls is fall-risk-increasing drugs (FRID). However, it is not known if the discontinuation of FRID leads to a reduction of falls. Therefore, the aim of this study was to assess the association between discontinuation of FRID and the occurrence of falls and recurrent falls. METHODS: This study included adults aged ≥ 70 years with multimorbidity and polypharmacy who were enrolled in a cluster randomized controlled trial assessing hospital pharmacotherapy optimization (OPERAM). Participants who were using FRID at baseline, were alive after 2 months of follow-up, and provided data on fall occurrence were included. FRID discontinuation was defined as discontinuation of ≥ 1 FRID within 2 months after inclusion, including the following groups: antidepressants, antiepileptics, antihistamines, antipsychotics, benzodiazepines and z-drugs, diuretics, opioids, and alpha-blockers. Multivariable cox regression analysis, using inverse probability weighting, was performed to assess the association between FRID discontinuation and the occurrence of falls. RESULTS: Our analysis included 1546 participants, with a median age of 79 years (IQR 74-84) and 45% female. After 2 months of follow-up, FRID were discontinued in 878 (57%) participants. Among all participants, 378 (24%) experienced a fall within 1 year of follow-up, with 137 (9%) of the participants experiencing two or more falls, and 199 (13%) participants experiencing a serious fall. No association was found between FRID discontinuation and the occurrence of falls. In a subgroup of participants with a previous fall, discontinuation of antipsychotics was associated with a lower occurrence of falls (HR 0.32 [CI 0.12-0.84], p = 0.02). CONCLUSIONS: In multimorbid older patients using FRID, falls are highly prevalent. No association was found between discontinuation of FRID and the risk of falls, except for the discontinuation of antipsychotics in patients who experienced a previous fall.
引用
- Goto NA, van Heel DAM, Dautzenberg L, et al. Impact of Discontinuation of Fall-Risk-Increasing Drugs on Falls in Multimorbid Older Patients With Polypharmacy. J Am Geriatr Soc. 2025. PMID: 40167043. doi:10.1111/jgs.19460
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。